Skip to main content
Optimind Pharma Corp. logo

Optimind Pharma Corp. — Investor Relations & Filings

Ticker · OMND CSE Human health and social work activities
Filings indexed 134 across all filing types
Latest filing 2023-06-29 Regulatory Filings
Country CA Canada
Listing CSE OMND

About Optimind Pharma Corp.

https://optimindpharma.com

Optimind Pharma Corp. is a provider specializing in psychedelic therapies and alternative treatments for mental health disorders. The company focuses on addressing conditions such as Post-Traumatic Stress Disorder (PTSD), anxiety, and depression. Optimind's core offerings include Psychedelic-Enhanced Psychotherapy (PEP) and Ketamine-Assisted Treatment (KAT). The treatment modalities encompass both monotherapy and assisted therapy, frequently utilizing ketamine capsules to facilitate therapeutic outcomes. Additionally, the company provides services related to the prescription of medical cannabis, integrating these various approaches to deliver comprehensive mental wellness solutions.

Recent filings

Filing Released Lang Actions
Audited annual financial statements – English.pdf
Regulatory Filings
2023-06-29 English
Annual MD&A - English.pdf
Regulatory Filings
2023-06-29 English
Notice of the meeting and record date (amended) - English.pdf
Regulatory Filings
2023-06-19 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2023-05-18 English
News release - English.pdf
Regulatory Filings
2023-03-10 English
Interim MD&A - English.pdf
Regulatory Filings
2023-01-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.